Biochips Market Outlook, Trends, Analysis, and Forecast to 2025- study by Coherent Market Insights

Biochips are little laboratories that are capable of carrying out many biological operations at once. Biochips are divided into four functional categories: DNA chips, protein chips, lab-on-a-chips, and tissue and cell arrays. A microscope slide comprised of materials like glass, silicon chips, and nylon membrane, which is printed with millions of tiny spots, is what makes up DNA chips, biochips, or DNA microarrays. These locations contain a recognised gene or DNA sequence in a systematic order. 

Biochips Market 
The cDNA microarray, Oligo DNA microarray, BAC microarray, and SNP microarray are some examples of DNA microarrays. DNA microarrays operate on the nucleic acid hybridization concept. Additionally, glass or silicon platforms with spots of proteins arranged at certain locations are found in protein microarrays and protein chips. These platforms interact with probe molecules in a high-throughput way.

By reducing the time and expense needed for traditional laboratory-based research methods, microfluidics and microarray technologies have transformed the area of scientific research. When compared to traditional laboratory methods, microfluidics has advantages such as lower assay costs because they require a smaller sample size in nano- or pico-liter volumes, lower labour costs, and higher sensitivity, accuracy, and throughput. Major fields like protein function, expression profiling, drug development, and biomarker discovery can all benefit from the use of protein arrays.

The global Biochips Market was valued at US$ 7,026.4 million in 2016 and is expected to witness a robust CAGR of 16.2% over the forecast period (2017 – 2025).

Products built using DNA microarray, protein chip, lab-on-a-chip, and organ-on-a-chip technologies have significantly reduced time and cost constraints in their respective fields of application. Over the projected period, continued research & development into microfluidic and microarray technologies for a variety of applications is also anticipated to fuel market expansion. For instance, the Griffith Institute for Drug Discovery (GRIDD) began developing a microfluidic platform in 2017 to further cut down on the time and money needed for research.

The increasing technical advances in biochips are the main factor driving the growth of the global biochips market. Additionally, as customised medicine is becoming increasingly used around the world, growing applications in cancer genomics are boosting market growth. The expanding applications of biochips over the forecast period are boosting the growth of the global Biochips market. However, because of the strict regulatory requirements and the expensive price of the instruments, the worldwide market may encounter limitations.

The Biochips Market is served by producers including CDI Laboratories, Inc., ThermoFisher Scientific, InDevR, Inc., Illumina, Inc., and Randox Laboratories. HuProt Proteome Microarray, ZikaProt (ZIKV/DENV) Proteome Microarray, Mycobacterium Tuberculosis (MTB) Proteome Microarray, GeneChip miRNA Array, Axiom genotyping array, and BovineSNP50 v3 DNA analysis beadchip are a few examples of commercially available biochips.

Get Press Release of Biochips Market

Comments

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Ginseng Market Outlook, Analysis and forecast up to 2028